Edesa Biotech, Inc. (EDSA)
4.84
+0.08
(+1.68%)
USD |
NASDAQ |
Sep 03, 15:04
Edesa Biotech 1 Year Total Returns (Daily) : 103.3% for Sept. 2, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 02, 2026 | 103.3% |
| September 01, 2026 | 106.0% |
| August 31, 2026 | 104.1% |
| August 28, 2026 | 93.31% |
| August 27, 2026 | 91.67% |
| August 26, 2026 | 103.3% |
| August 25, 2026 | 83.88% |
| August 24, 2026 | 83.33% |
| August 21, 2026 | 86.13% |
| August 20, 2026 | 102.1% |
| August 19, 2026 | 147.8% |
| August 18, 2026 | 151.3% |
| August 17, 2026 | 152.8% |
| August 14, 2026 | 136.7% |
| August 13, 2026 | 147.9% |
| August 12, 2026 | 144.2% |
| August 11, 2026 | 161.6% |
| August 10, 2026 | 147.2% |
| August 07, 2026 | 152.2% |
| August 06, 2026 | 124.4% |
| August 05, 2026 | 128.8% |
| August 04, 2026 | 136.6% |
| August 03, 2026 | 144.4% |
| July 31, 2026 | 127.1% |
| July 30, 2026 | 131.3% |
| Date | Value |
|---|---|
| July 29, 2026 | 134.1% |
| July 28, 2026 | 113.3% |
| July 27, 2026 | 124.8% |
| July 24, 2026 | 118.8% |
| July 23, 2026 | 137.8% |
| July 22, 2026 | 133.7% |
| July 21, 2026 | 150.2% |
| July 20, 2026 | 142.5% |
| July 17, 2026 | 178.5% |
| July 16, 2026 | 197.3% |
| July 15, 2026 | 215.1% |
| July 14, 2026 | 206.4% |
| July 13, 2026 | 225.8% |
| July 10, 2026 | 238.6% |
| July 09, 2026 | 233.5% |
| July 08, 2026 | 256.6% |
| July 07, 2026 | 254.4% |
| July 06, 2026 | 246.6% |
| July 02, 2026 | 267.6% |
| July 01, 2026 | 281.8% |
| June 30, 2026 | 300.5% |
| June 29, 2026 | 274.1% |
| June 26, 2026 | 319.6% |
| June 25, 2026 | 272.6% |
| June 24, 2026 | 297.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ProMIS Neurosciences, Inc. | 4.17% |
| Arrowhead Pharmaceuticals, Inc. | 232.4% |
| Oncolytics Biotech, Inc. | -23.48% |
| Sangamo Therapeutics, Inc. | -68.30% |
| Sarepta Therapeutics, Inc. | 27.81% |